Last checked at 23 Dec 2009 07:01
Craneware plc
("Craneware" or the "Company")
Grant of Options
23 December 2009 - The Board of Craneware plc (AIM: CRW.L), the market leader in automated revenue integrity solutions for the US healthcare market, announces that on 22 December 2009, the Remuneration Committee approved the granting of share options to certain Directors to subscribe for ordinary shares of 1p each in the Company as follows:
| Director | No. of options granted | Percentage of issued share capital |
| Keith Neilson (Chief Executive Officer) | 42,870 | 0.17 |
| Craig Preston (Chief Financial Officer) | 37,649 | 0.15 |
The above options have been granted at an exercise price of 335p per share. These options will be subject to performance criteria, such that they vest in three equal tranches over three years. One third of the share options will vest on or after 30 June 2010, one third on or after 30 June 2011 and the final third on or after 30 June 2012. The share options will not become exercisable until three years from the date of the grant.
For further information, please contact:
| Craneware plc | KBC Peel Hunt | ICIS |
| +44 (0)1506 407 666 | +44 (0)20 7418 8900 | +44 (0)20 7651 8688 |
| Keith Neilson, CEO | Jonathan Marren | Caroline Evans-Jones |
| Craig Preston, CFO | Richard Kauffer | Fiona Conroy |
About Craneware
Founded in 1999, Craneware has headquarters in Livingston, Scotland, with offices in Florida, Arizona and Kansas, employing over 100 staff. Craneware partners with healthcare organisations to improve returns, increase productivity and manage risk, driving better financial and operational performance using market-driven revenue management solutions. By enhancing revenue capture processes, Craneware solutions enable healthcare organisations to optimise reimbursement, improve operational efficiency, and support compliance. Visit craneware.com.